• 1
    Van Everdingen AA, Jacobs JW, Siewertsz van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease modifying properties and side effects: a double-blind placebo controlled clinical trial. Ann Intern Med 2002; 136: 112.
  • 2
    Kirwan JR, and the Arthritis and Rheumatism Council Low-dose Glucocorticoid Study Group. The effect of glucocorticoid on joint destruction in RA. N Engl J Med 1995; 333: 1426.
  • 3
    Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisone, methotrexate and sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 30918.
  • 4
    Hickling P, Jacoby RK, Kirwan JR and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Br J Rheumatol 1998; 37: 9306.
  • 5
    Zeidler H, Rau R, Steinfeld P for the Low Dose Prednisone Therapy (LPDT) Study Group. Efficacy and safety of low-dose prednisone in early rheumatoid arthritis [abstract]. Arthritis Rheum 1999; 42 Suppl 9: S271.
  • 6
    Jacobs JW, Geenen R, Evers AW, van Jaarsveld CH, Kraaimaat FW, Bijlsma JW. Short term effects of corticosteroid pulse treatment on disease activity and the well-being of patients with active rheumatoid arthritis. Ann Rheum Dis 2001; 60: 614.
  • 7
    Schmidt LA, Fox NA, Goldberg MC, Smith CC, Schulkin J. Effects of acute prednisone administration on memory, attention and emotion in healthy human adults. Psychoneuroendocrinology 1999; 24: 46183.
  • 8
    Brown ES, Suppes T. Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry 1998; 5: 239-46.
  • 9
    Booij A, Biewenga-Booij CM, Huber-Bruning O, Cornelis C, Jacobs JW, Bijlsma JW. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis 1996; 55: 8115.
  • 10
    Jacobs JW, Kraaimaat FW, Bijlsma JWJ. Why do patients with rheumatoid arthritis use alternative treatments? Clin Rheumatol 2001; 20: 1926.
  • 11
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1998; 31: 31524.
  • 12
    Felson DT, Andreson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 72735.
  • 13
    Bijlsma JWJ, Oude Heuvel CHB, Zaalberg A. Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis. J Rehabil Sci 1990; 3: 714.
  • 14
    Huiskes CJAE, Kraaimaat FW, Bijlsma JWJ. Development of a self-report questionnaire to assess the impact of rheumatic diseases on health and lifestyle. J Rehabil Sci 1990: 3: 6574.
  • 15
    Evers AWM, Taal E, Kraaimaat FW, Jacobs JW, Abdel-Nasser A, Rasker, JJ, et al. A comparison of two recently developed health status instruments for patients with arthritis: Dutch-AIMS2 and IRGL. Br J Rheumatol 1998; 37: 15764.
  • 16
    Smolen JS, Breedveld FC, Eberl G, Jones I, Leeming M, Wylie GL, et al. Validity and reliability of the twenty-eight–joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 1995; 38: 3843.
  • 17
    Prevoo ML, van Riel PL, van 't Hof MA, van Rÿswÿk MH, van Leeuwen MA, Kuper HH, et al. Validity and reliability of joint indices: a longitudinal study in patients with recent onset rheumatoid arthritis. Br J Rheumatol 1993; 32: 58994.
  • 18
    Van der Heijde DM, van Riel PL, van Leeuwen MA, van 't Hof MA, van Rijswijk MH, van de Putte LB. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: a prospective follow-up study of 147 patients. Br J Rheumatol 1992; 31: 51925.
  • 19
    Van der Heide A, Jacobs JW, Dinant HJ, Bijlsma JWJ. The impact of endpoint measures in rheumatoid arthritis clinical trials. Semin Arthritis Rheum 1992; 21: 28794.
  • 20
    Van der Heide A, Jacobs JW, van Albada-Kuipers GA, Kraaimaat FW, Geenen R, Bijlsma JW. Self report functional disability scores and the use of devices: two distinct aspects of physical function in rheumatoid arthritis. Ann Rheum Dis 1993; 52: 497502.
  • 21
    Welsing PMJ, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001; 44: 2009117.
  • 22
    Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 2000; 43: 275161.